Informationen:
Fehler:
ID
26789
Beschreibung
Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00893061
Link
https://clinicaltrials.gov/show/NCT00893061
Stichworte
Versionen (1)
- 24.10.17 24.10.17 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
24. Oktober 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Breast Cancer NCT00893061
Eligibility Breast Cancer NCT00893061
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Breast Cancer NCT00893061
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Breast Carcinoma
Item
histologically confirmed breast cancer
boolean
C0678222 (UMLS CUI [1])
Exclusion Neoplasm Metastasis
Item
no metastatic disease
boolean
C2828389 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,2])
Hormone Therapy Adjuvant
Item
meets criteria for initiating adjuvant endocrine therapy
boolean
C0279025 (UMLS CUI [1,1])
C1522673 (UMLS CUI [1,2])
C1522673 (UMLS CUI [1,2])
Hormone Receptor Status
Item
hormone receptor status:
boolean
C0019929 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
C0449438 (UMLS CUI [1,2])
Disease Estrogen receptor positive | Disease Progesterone receptor positive
Item
estrogen receptor- and/or progesterone receptor-positive disease
boolean
C0012634 (UMLS CUI [1,1])
C0279754 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0279759 (UMLS CUI [2,2])
C0279754 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0279759 (UMLS CUI [2,2])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Postmenopausal state | Menstruation absent Duration FSH measurement | Menstruation absent Duration Estradiol Measurement
Item
postmenopausal, defined as no menstruation for ≥ 1 year, confirmed by a measurement of fsh and 17-beta-estradiol
boolean
C0232970 (UMLS CUI [1])
C0497456 (UMLS CUI [2,1])
C0449238 (UMLS CUI [2,2])
C0202022 (UMLS CUI [2,3])
C0497456 (UMLS CUI [3,1])
C0449238 (UMLS CUI [3,2])
C0014912 (UMLS CUI [3,3])
C0242485 (UMLS CUI [3,4])
C0497456 (UMLS CUI [2,1])
C0449238 (UMLS CUI [2,2])
C0202022 (UMLS CUI [2,3])
C0497456 (UMLS CUI [3,1])
C0449238 (UMLS CUI [3,2])
C0014912 (UMLS CUI [3,3])
C0242485 (UMLS CUI [3,4])
Karnofsky Performance Status
Item
karnofsky performance status 80-100%
boolean
C0206065 (UMLS CUI [1])
Native speaker French language
Item
native speaker of french
boolean
C0814951 (UMLS CUI [1,1])
C0376246 (UMLS CUI [1,2])
C0376246 (UMLS CUI [1,2])
Insurance Beneficiary Social Security
Item
beneficiary of a french social security insurance plan
boolean
C3853043 (UMLS CUI [1,1])
C0037435 (UMLS CUI [1,2])
C0037435 (UMLS CUI [1,2])
Exclusion | Cognition Disorders
Item
no prior cognitive disorders
boolean
C2828389 (UMLS CUI [1])
C0009241 (UMLS CUI [2])
C0009241 (UMLS CUI [2])
Exclusion Criteria | Depressive disorder | Mental disorders
Item
no depression or other confirmed active psychiatric disease
boolean
C0680251 (UMLS CUI [1])
C0011581 (UMLS CUI [2])
C0004936 (UMLS CUI [3])
C0011581 (UMLS CUI [2])
C0004936 (UMLS CUI [3])
Monitoring Receive Ability
Item
able to undergo the medical monitoring of the trial due to geographic, social or psychological reasons
boolean
C1516647 (UMLS CUI [1,1])
C1514756 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
C1514756 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
Exclusion Criteria | Thromboembolism | Family history Thromboembolism
Item
no personal or family history of thromboembolic disease
boolean
C0680251 (UMLS CUI [1])
C0040038 (UMLS CUI [2])
C0241889 (UMLS CUI [3,1])
C0040038 (UMLS CUI [3,2])
C0040038 (UMLS CUI [2])
C0241889 (UMLS CUI [3,1])
C0040038 (UMLS CUI [3,2])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Exclusion Adjuvant Chemotherapy
Item
no prior adjuvant chemotherapy
boolean
C2828389 (UMLS CUI [1,1])
C0085533 (UMLS CUI [1,2])
C0085533 (UMLS CUI [1,2])
Exclusion | Study Subject Participation Status | Clinical Study Follow-up
Item
no concurrent follow-up participation on another study
boolean
C2828389 (UMLS CUI [1])
C2348568 (UMLS CUI [2])
C3274571 (UMLS CUI [3])
C2348568 (UMLS CUI [2])
C3274571 (UMLS CUI [3])
Exclusion Criteria | Psychotropic Drugs | Benzodiazepines | Antipsychotic Agents | Cholinesterase Inhibitors
Item
no concurrent treatment with psychotropic substances (i.e., long half life benzodiazepines, antipsychotics, anticholinesterase)
boolean
C0680251 (UMLS CUI [1])
C0033978 (UMLS CUI [2])
C0005064 (UMLS CUI [3])
C0040615 (UMLS CUI [4])
C0008425 (UMLS CUI [5])
C0033978 (UMLS CUI [2])
C0005064 (UMLS CUI [3])
C0040615 (UMLS CUI [4])
C0008425 (UMLS CUI [5])